Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Depreciation & Amortization (CF) (2020 - 2026)

Immuneering's Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $81402.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 4.53% to $81402.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $320659.0, a 8.61% decrease, with the full-year FY2025 number at $324517.0, down 8.79% from a year prior.
  • Depreciation & Amortization (CF) came in at $81402.0 for Q1 2026, up from $75889.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $90533.0 in Q2 2024, with the low at $47704.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $78337.9 across 5 years, with a median of $78841.0 in 2025.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 468.33% in 2022 and later fell 11.88% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $76862.0 in 2022, then rose by 16.77% to $89754.0 in 2023, then decreased by 4.05% to $86116.0 in 2024, then decreased by 11.88% to $75889.0 in 2025, then increased by 7.26% to $81402.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for IMRX at $81402.0 in Q1 2026, $75889.0 in Q4 2025, and $78841.0 in Q3 2025.